Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021

To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0–14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (...

Descripción completa

Detalles Bibliográficos
Autores principales: Mateo-Urdiales, Alberto, Spila Alegiani, Stefania, Fabiani, Massimo, Pezzotti, Patrizio, Filia, Antonietta, Massari, Marco, Riccardo, Flavia, Tallon, Marco, Proietti, Valeria, Del Manso, Martina, Puopolo, Maria, Spuri, Matteo, Morciano, Cristina, D’Ancona, Fortunato (Paolo), Da Cas, Roberto, Battilomo, Serena, Bella, Antonino, Menniti-Ippolito, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229378/
https://www.ncbi.nlm.nih.gov/pubmed/34169819
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.25.2100507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229378/
https://www.ncbi.nlm.nih.gov/pubmed/34169819
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.25.2100507

Ejemplares similares